Elephas

Elephas Biosciences

This company develops a live tissue platform for predicting immunotherapy response to assist oncologists, researchers, and pharmaceutical developers in cancer treatment.

Orbits Oncology

Orbits Oncology develops an AI-powered image analysis platform for cancer organoid drug screening and therapy matching for biopharma companies and oncologists.

Xilis

Xilis develops miniature patient-derived tumour models for precision oncology and drug discovery, serving clinicians and pharmaceutical companies.

Voyant Bio

Voyant Bio develops a spatial intelligence atlas of immune cell interactions to design precision immunotherapies for cancer patients.

Pear Bio

The company develops a precision medicine platform using microfluidic chips and computer vision to predict cancer treatment efficacy for oncologists and pharmaceutical researchers.

TileBio

TileBio develops artificial intelligence foundation models for digital pathology to assist clinicians and pharmaceutical companies with cancer diagnosis, biomarker discovery and drug development.

PolaSight

PolaSight develops a polarimetric imaging device for real-time tissue assessment for pathologists to accelerate intraoperative workflows during cancer surgery.

One Biosciences

One Biosciences develops an AI-powered single-cell transcriptomic platform to provide functional tumour profiling for oncologists and pharmaceutical companies.